Company profile: Stratos Genomics
1.1 - Company Overview
Company description
- Provider of Sequencing by Expansion (SBX), a single-molecule detection process that enables whole-genome sequencing.
Products and services
- Sequencing by Expansion (SBX): A single-molecule detection process enabling whole-genome sequencing for complete genomic coverage, developed by Stratos Genomics to analyze entire genomes using single-molecule detection
- Single-Molecule Detection Process: Architects detection at the single-molecule scale used in SBX, enabling whole-genome sequencing applications that interrogate entire genomes as a core capability
- Whole-Genome Sequencing Capability: Builds whole-genome sequencing enabled by SBX’s single-molecule detection process, focusing on complete genome analysis derived from detecting individual molecules as described
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Stratos Genomics
Scioto Biosciences
HQ: United States
Website
- Description: Provider of Activated Bacterial Therapeutics, including SB-121, a formulation of L. reuteri with Sephadex and maltose designed to deliver activated probiotic bacteria to the gastrointestinal tract for treating autism spectrum disorder and potentially other GI disorders, and an ABT platform that enhances delivery and efficacy of live bacterial therapeutics for GI health and diseases affecting the gut-brain axis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Scioto Biosciences company profile →
Q Chip
HQ: United Kingdom
Website
- Description: Provider of biopharmaceutical drug delivery, developing a range of sustained-release biogeneric and biotherapies products (Q-Sphera).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Q Chip company profile →
Gemini Bio
HQ: United States
Website
- Description: Provider of FDA-registered biological products and chemical reagents for the global cell culture community, offering cell culture sera (fetal bovine and other human/animal), custom and specialized media and buffers, supplements and reagents (amino acids, antibiotics, antimycotics), high purity water including WFI-quality, and cGMP contract manufacturing/private-label process liquids.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Gemini Bio company profile →
Amnis
HQ: United States
Website
- Description: Provider of flow cytometry products and services used in research and clinical studies, including investigating the immune system in fighting cancer, diagnosing leukemia and lymphoma, and detecting minimal residual disease in organ transplant. Offers Cytek Aurora spectral cytometer, Aurora CS cell sorter, Northern Lights, Orion reagent prep, ESP Detection Option, and Cytek Amnis AI v3.0 image analysis software.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Amnis company profile →
Brooks Running
HQ: United States
Website
- Description: Provider of automation, vacuum, and instrumentation solutions for the worldwide semiconductor manufacturing industry, including wafer handling robotics and integrated tool automation systems, vacuum and atmospheric robots, configurable transfer and transport platforms (MagnaTran LEAP, Marathon LEAP AX, Marathon Express), and pathology lab automation (PathFinder Benchtop, Tube Decapper).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Brooks Running company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Stratos Genomics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Stratos Genomics
2.2 - Growth funds investing in similar companies to Stratos Genomics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Stratos Genomics
4.2 - Public trading comparable groups for Stratos Genomics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →